Trane Technologies holder plans sale of 987 shares

A shareholder of Trane Technologies (TT) has filed a notice to sell 987 shares of common stock under Rule 144.

Rhea-AI Filing Summary

A shareholder of Trane Technologies (TT) has filed a notice to sell 987 shares of common stock under Rule 144. The shares are planned to be sold on the NYSE through UBS Financial Services, Inc., with an aggregate market value of $438,918.90.

The shares were acquired from the issuer on 02/04/2026 via an RSU (restricted stock unit) transaction, with payment on the same date. The filing notes that 221,331,905 shares of the issuer’s common stock were outstanding, providing a baseline for the company’s equity as of the notice.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Trane Technologies (TT) Form 144 filing disclose?

The filing discloses a planned sale of 987 shares of Trane Technologies common stock under Rule 144. The shares are to be sold on the NYSE through UBS Financial Services with an aggregate market value of $438,918.90.

How many Trane Technologies (TT) shares are being sold and at what value?

The notice covers a proposed sale of 987 common shares of Trane Technologies. The filing lists an aggregate market value of $438,918.90 for these shares, with trading expected to occur on the NYSE through UBS Financial Services, Inc.

How and when were the Trane Technologies (TT) shares being sold acquired?

The 987 shares planned for sale were acquired on 02/04/2026 via an RSU (restricted stock unit) transaction from the issuer. The filing also indicates the date of payment as 02/04/2026, matching the acquisition date.

When is the planned sale date for the Trane Technologies (TT) shares?

The filing lists an approximate date of sale of 02/06/2026 for the 987 common shares. The shares are expected to be sold on the NYSE, with UBS Financial Services, Inc. named as the broker handling the transaction.

How many Trane Technologies (TT) shares are outstanding in this Form 144?

The Form 144 states that 221,331,905 shares of Trane Technologies common stock were outstanding. This figure provides context for the company’s total equity base relative to the 987 shares that are planned to be sold under Rule 144.

What representation does the seller make in the Trane Technologies (TT) Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about Trane Technologies’ current or prospective operations that has not been publicly disclosed, consistent with the standard Rule 144 certification language included in the form.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/06/2026 - 04:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001715932
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Trane Technologies plc
SEC File Number	001-34400
Address of Issuer	170/175 LAKEVIEW DRIVE AIRSIDE BUSINESS PARK, SWORDS, CO. DUBLIN IRELAND 00000
Phone	732-652-7000
Name of Person for Whose Account the Securities are To Be Sold	Regnery David S
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	987	438918.90	221331905	02/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/04/2026	RSU	Issuer			987	02/04/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/02/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for David Regnery
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)